Skip to main content
Premium Trial:

Request an Annual Quote

Epigenomics' Q2 Revenues Dwindle 17 Percent, R&D Rises in Dx Push

NEW YORK (GenomeWeb News) — Epigenomics today said second-quarter revenue fell 17 percent as R&D spending rose 17 percent and net loss decreased 21 percent.
 
Total receipts for the three months ended June 30 fell to €524,000 ($718,000) from €628,000 year over year.
 
The company said €511,000 of its €1.3 million total half-year revenue came from residuals from a collaboration with Roche Diagnostics, which officially ended in March.
 
R&D spending increased to €2.8 million from €2.4 million year over year.
 
Net loss was €3.4 million, compared with €4.3 million in the year-ago period.
 
Epigenomics said it had around €16.6 million in liquid assets as of June 30.
 
The company said it expects full-year 2007 revenue to be “similar” to the €3.5 million it posted in 2006.
 
Epigenomics’ CEO Geert Nygaard said the company made “significant progress” in the second quarter toward the commercialization of its cancer molecular diagnostic tests.
 
The company said it has “completed preparations” to raise equity capital over the next 12 months. “The exact timing will depend upon Epigenomics' progress in executing the strategy and delivering on its plans, in particular the structuring of an IVD deal, as well as prevailing market conditions,” the firm said.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.